MedPath

Novel Anti-Infective Technologies, LLC

Ownership
Private
Employees
-
Market Cap
-
Website

Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution

Phase 1
Completed
Conditions
Catheter-Associated Infections
Catheter-Related Infections
Interventions
Drug: Nitroglycerin-citrate-ethanol (NiCE)
First Posted Date
2015-10-16
Last Posted Date
2017-11-06
Lead Sponsor
Novel Anti-Infective Technologies, LLC
Target Recruit Count
60
Registration Number
NCT02577718
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath